News & Updates

After a recent survey we conducted, it is clear most clinicians agreed skin substitutes are highly effective and essential, warning that the proposed rates would reduce patient access, hinder innovation, and threaten the viability of many practices. Read the blog to learn more about our findings.

Proposed Medicare Cuts To Skin Substitutes Could Force Wound Care Clinicians Out, Putting Thousands of Patients at Risk.

Mobile wound care is a critical yet often misunderstood part of chronic wound management, providing advanced treatment to patients who can't easily access traditional care. Far from being a fringe service, it’s a large and growing field—with nearly 30,000 clinicians billing for mobile wound services in 2023 alone—and plays a key role in addressing the rising burden of chronic wounds, especially in nursing homes. As wound severity increases, staffing shortages persist, and the population ages, mobile providers are filling care gaps through high-volume, high-quality services and innovative tools like AI-assisted telehealth and near-infrared spectroscopy. To ensure better outcomes and lower healthcare costs, policymakers and payers must recognize mobile wound care as an essential, professional solution—not a peripheral one.

Venture Medical, LCC is sharing our position on the CY2026 Medicare Physician Fee Schedule and our future recommendations.

If we want reimbursement systems that reflect real-world care and outcomes, we need to speak up. The comment period is now open. Read the full breakdown from John Schroeder and Howard Walthall to learn more about how you can join the call for fair, evidence-based reimbursement.

Venture Medical, a leader in wound care solutions, stands at the forefront of advocating for patient access and innovation in response to the 2026 Hospital Outpatient Prospective Payment System (OPPS) proposed rule.

Venture Medical announces the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing.

Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio

In an industry where innovation and adaptability are key, Venture Medical, LLC has carved out a unique space, blending bold ambition with a steadfast commitment to quality and service. Over the past few years, the company has experienced exponential growth, but what truly sets Venture apart isn’t just its expansion—it’s the culture, leadership philosophy, and relentless pursuit of excellence that fuel its success.

On Monday during his first day in office, President Trump signed an Executive Order (EO) freezing the pending LCD policy that would limit access to skin substitutes for chronic wound care. To be clear - this is a policy freeze pending further action.

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Venture Medical, LLC has been announced as the exclusive distributor of Vendaje AC®, a wound care product manufactured by BioStem Technologies Inc. (OTC: BSEM).

Under a system previously reliant solely on hospital outpatient departments, many patients—especially the elderly in care facilities, the poor, the homebound, the rural, and the otherwise disenfranchised—never enjoyed equitable access. Today, however, more patients than ever are receiving wound care as providers are motivated to bring advanced modalities directly to them.

“Explore the fascinating realm of microbiology and healthcare in the MicroGenDX Mic’d Up podcast, hosted by Rick Martin, CEO of MicroGenDX. Join Rick and his special guest, the esteemed Caroline Fife, MD, FAAFP, CWS, Professor of Medicine at Baylor College of Medicine

The national ASP publication of AmnioWrap2™ knocks down barriers that will provide healthcare professionals and their patients with the opportunity to use AmnioWrap2™, a superior wound care product for certain applications.

Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials.

Get a first-hand look at the application process of the Venture Medical Sacral Dressing Kit in this short video. We illustrate the kit's key role in protecting wounds from contaminants for patients with pressure ulcers who also suffer from incontinence. The demonstration also highlights how this kit supports the performance of advanced treatments such as CTPs. Learn to enhance your wound care practices and promote better wound healing with this cutting-edge solution.